ROLE OF POSTTRANSLATIONAL PROTEIN MODIFICATIONS IN DIABETIC CARDIOMYOPATHY
ROLE OF POSTTRANSLATIONAL PROTEIN MODIFICATIONS IN DIABETIC CARDIOMYOPATHY
批准号:
7720684
负责人:
Irina I Smirnova
金额:
$5.26万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-05-15 至 2009-03-31
关键词:
AnimalsAreaAutoimmune ProcessCardiacCardiovascular systemChronicComputer Retrieval of Information on Scientific Projects DatabaseConditionDevelopmentDiabetes MellitusDigestionDiseaseFractionationFunctional disorderFundingGelGoalsGrantHeartHumanHyperglycemiaInstitutionInsulin-Dependent Diabetes MellitusInterventionLeftLeft ventricular structureLinkMALDI-TOF Mass SpectrometryModificationMolecularMyocardiumPathologyPathway interactionsPopulationPost-Translational Protein ProcessingProteinsResearchResearch PersonnelResearch Project GrantsResourcesRoleSiteSourceStructureThinkingTissuesUnited States National Institutes of HealthVentriculardiabeticdiabetic cardiomyopathydiabetic ratintracellular protein transportmortalityprotein localization locationtherapeutic target
中文摘要
这个子项目是许多研究子项目中的一个
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得了主要资金,
因此可以在其他CRISP条目中表示。所列机构为
研究中心,而研究中心不一定是研究者所在的机构。
6%的美国人口患有糖尿病,其中心血管并发症导致的死亡率最高。糖尿病性心肌病是一种慢性疾病,其特征是功能受损和心肌形态结构改变。这种病理学的分子机制还不清楚,但高血糖被认为是其发展的主要病因。糖尿病心脏中的许多蛋白质由于其表达水平和/或结构的变化而显示出深刻的功能改变。蛋白质翻译后修饰的变化与多种疾病状态有关;然而,这一领域在糖尿病心脏功能障碍中的研究很少。本研究项目的目的是确定可能导致糖尿病心肌病发展的心脏蛋白质修饰的分子机制。
本研究中将使用自身免疫性糖尿病大鼠模型(最接近人类1型糖尿病的动物对应物),并将分析左心室组织,因为糖尿病性心脏功能障碍最初在左心室中发展。我们将进行糖尿病心脏蛋白的分级分离,分离使用2D-PAGE,凝胶内消化,和鉴定postperformantly修饰的蛋白质和使用MALDI-TOF质谱法的修改网站的本地化。此外,我们将揭示糖尿病心脏蛋白质中这种修饰的可能机制。在研究完成后,我们将更好地了解糖尿病心肌病发展中涉及的分子途径,这将允许识别用于治疗靶向的候选蛋白质。该项目将有助于我们的长期研究目标,即阐明糖尿病对心脏有害影响的机制,并确定有效的干预措施来阻止这种病理状态。
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Six percent of the USA population suffers from diabetes mellitus, with the greatest mortalities caused by cardiovascular complications. Diabetic cardiomyopathy is a chronic condition and is characterized by impaired function and alterations in the morphological structure of the heart muscle. The molecular mechanisms underlying this pathology are not well understood, however hyperglycemia is thought to be the main etiological factor in its development. Many proteins in the diabetic heart show profoundly altered function, due to changes in their expression level and/or structure. Changes in posttranslational modifications of proteins have been linked to a variety of disease states; however, this area is poorly explored in the malfunctioning diabetic heart. The objective of this research project is to identify the molecular mechanisms responsible for cardiac protein modification that may contribute to development of diabetic cardiomyopathy.
The autoimmune diabetic rat model, the closest animal counterpart of human type 1 diabetes, will be used in this study, and left ventricular tissue will be analyzed as diabetic heart dysfunction initially develops in the left ventricle. We will perform diabetic heart protein fractionation, separation using 2D-PAGE, in-gel digestion, and identification of posttranslationally modified proteins and localization of the modified sites using MALDI-TOF mass spectrometry. In addition we will uncover possible mechanisms of such modifications in cardiac proteins in diabetes. At the completion of the study we will have better understanding of the molecular pathways involved in the development of diabetic cardiomyopathy that will allow to identify candidate proteins for therapeutic targeting. This project will contribute to our long-term research goal which is to elucidate the mechanisms responsible for the detrimental effects of diabetes in the heart, and to identify effective interventions to halt this pathological condition.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: